Tanya Nanda
About Tanya Nanda
Tanya Nanda is a Quality Assurance Technologist and Research Editor currently working at Castle Biosciences, Inc. and Arizona State University in Tempe, Arizona, with a strong background in molecular biology and diagnostics.
Work at Castle Biosciences
Tanya Nanda currently holds two positions at Castle Biosciences, Inc. in Phoenix, Arizona. She has been serving as a Quality Assurance Technologist since 2021, where she focuses on ensuring the quality and reliability of the company's products and services. In addition, she works as a Molecular Technologist specializing in Next Generation Sequencing (NGS), also starting in 2021. Her roles involve developing and validating pipelines and gene panels for detecting clinically significant mutations in melanoma.
Education and Expertise
Tanya Nanda earned her Master of Science in Bioengineering and Biomedical Engineering from Arizona State University, completing her studies from 2019 to 2020. She also holds a Bachelor's Degree in Biotechnology from UIET Panjab University, which she obtained from 2014 to 2018. Her graduate thesis investigated the role of the tumor microenvironment in cancer cell dormancy. Tanya specializes in molecular biology and diagnostics, with skills in DNA/RNA/Protein isolation, bacterial and organoid culture, and cancer biology.
Background
Tanya Nanda has a diverse background in research and academia. She has worked at various institutions, including Arizona State University, where she held multiple roles such as Teaching Assistant and Graduate Research Assistant. Her experience also includes internships and fellowships at organizations like the Translational Genomics Research Institute and the National Institutes of Health. Tanya has developed extensive laboratory skills and has been involved in projects related to tumor technology and therapeutics.
Achievements
Tanya Nanda has contributed to significant research in the field of cancer biology and diagnostics. She has a pending patent for technology related to engineering three-dimensional microbead encapsulated dormant tumor models. Additionally, she has developed and validated gene panels for detecting mutations in melanoma. Her work has been supported by various research grants and awards, highlighting her contributions to tumor technology and therapeutics.